GLP-1 weight loss injections such as Ozempic and Mounjaro can cost hundreds of dollars a month without health insurance coveragewhich seems steep for a drug that mimics a hormone your body makes naturally
Segn las guas de la American Diabetes Association (ADA), los agonistas de receptores GLP-1 son recomendados para pacientes con diabetes tipo 2 que tienen enfermedad cardiovascular establecida, alto riesgo cardiovascular, enfermedad renal crnica o necesidad de prdida de peso, como parte de un enfoque de tratamiento centrado en el paciente
Pharma players should explore both horizontal (e.g., biotech in-licensing, M&A) and vertical (e.g., contract development and manufacturing organizations (CDMOs), device suppliers) partnerships to enhance capabilities
These findings suggest that B7-H5 could serve as both a predictive biomarker and a potential therapeutic target
As more GLP-1s are offered in oral form and generic competition production ramps up, global use of the drugs is expected to surge
Pre-existing conditions or nutritional gaps from reduced food intake could also contribute to low energy